Capgemini (ENXTPA:CAP) has partnered with Orano to launch an intelligent humanoid robot designed for nuclear facility operations. New robots combine artificial intelligence and advanced sensors to tackle demanding industrial environments.
Check out our latest analysis for Capgemini.
Capgemini’s announcement of an AI-powered humanoid robot comes just as the stock is showing signs of new momentum, rising more than 8% in the past week and 9% this month. Year-to-date stock returns have remained negative. Long-term total shareholder returns are still recovering after a tough year, but recent product launches and industry alliances suggest there may be growing optimism among investors looking for growth catalysts.
Interested in where technology meets opportunity? Take the next step to see the complete list for free.
Despite the recent rally, the stock is still trading at a significant discount to analysts’ price targets, so the real question is whether Capgemini is undervalued or whether the market has already priced in all of its growth potential.
Most popular story: 22.4% are underrated
Capgemini’s most popular story has priced its fair value well above its recent closing price, underscoring analyst optimism about its earnings power and future prospects. This valuation assumes a future valuation based on projected business growth rather than short-term market sentiment.
With Capgemini’s growing leadership and strong deal wins in advanced cloud, data and artificial intelligence (including Gen AI and Agentic AI), the company stands to benefit from accelerating customer demand for digital transformation. This supports a pipeline of higher-value, higher-margin contracts that drive long-term revenue and profit growth.
Read the whole story.
Want to know the future assumptions that justify such a high valuation? The answer includes bold growth forecasts and ambitious revenue targets. Only by reading the full article will you find out the key numbers and high-stakes predictions that support the price. Prepare to be amazed.
Result: Fair value $171.93 (undervalued)
Read the full explanation to understand what’s behind the predictions.
However, continued challenges and increasing competition in European demand could easily disrupt Capgemini’s growth trajectory and put pressure on its ambitious forecasts.
Learn about the key risks in this Capgemini story.
Build your own Capgemini story
If you want to dig deeper or see things differently, you can build your own Capgemini analysis in just a few minutes. do it your way
A great starting point for Capgemini’s research is our analysis that highlights 3 key benefits and 1 key warning sign that could influence your investment decision.
Looking for more investment ideas?
Why rely on a single stock when you can enhance your portfolio with new opportunities? Take advantage of some of the market’s most exciting trends below.
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
new: AI stock screener and alerts
Our new AI Stock Screener scans the market for opportunities every day.
• Dividend powerhouse (yield 3% or more)
• Small-cap stocks that are undervalued due to insider purchases.
• High-growth technology and AI companies
Or build your own metrics from over 50 metrics.
Explore for free now
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.
